Collagen Powders and Microbial Risk: What USP <61> and <62> Testing Reveals About Animal-Derived Raw Materials

The collagen supplement category grew at roughly 8.4% annually between 2019 and 2024, and U.S. retail sales now exceed $2.3 billion per year. For Midwest supplement brands scaling collagen SKUs — bovine peptide powders, marine hydrolysates, porcine gelatin blends — that growth has attracted a lot of new suppliers and, with them, a lot of new quality risk.

Most brands treat collagen the way they’d treat any other protein powder: request a COA, check the total plate count, receive the drum. That approach works reasonably well for chemically synthesized ingredients with predictable microbial profiles. For animal-derived raw materials, it’s a meaningful gap in your quality program.

The Animal-Derived Distinction: Why Collagen Requires a Different Microbial Framework

Collagen is produced through acid or alkaline hydrolysis of bovine hide, bovine bone, or porcine skin — materials that arrive at the processing facility with an inherently complex microbiological starting point. Slaughterhouse environments are well-documented sources of Salmonella spp. and E. coli O157:H7; FDA inspection records of meat processing facilities routinely identify these organisms surviving in equipment biofilms and floor drains, even in facilities with active HACCP programs.

Hydrolysis does significant pathogen reduction work. A properly run acid hydrolysis at pH 1–3, followed by heat treatment at 80°C for 30 minutes or more, generates at least a 6 log₁₀ reduction in Salmonella populations — a million-fold decrease. Marine collagen, derived from fish skin or scales, carries a somewhat different profile: lower Salmonella concern, higher mold susceptibility, and greater Pseudomonas aeruginosa risk in humid storage.

But the reduction isn’t the endpoint of the risk story. Every step between the hydrolysis tank and your blending floor is a re-introduction opportunity. And those post-processing steps — spray drying, milling, bagging, drumming, transshipping across two continents — are exactly where your supplier’s in-house QC often has the least visibility.

What USP <61> and <62> Actually Measure — And Why You Need Both

These chapters are frequently conflated in procurement conversations, and the confusion leads to incomplete testing programs.

USP <61> (Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests) is quantitative. It answers: how many organisms are present? The two primary outputs are Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC), both in colony-forming units per gram (CFU/g).

USP <62> (Tests for Specified Organisms) is qualitative and targeted. It answers: are specific pathogens present? For dietary supplement raw materials, the standard panel covers Salmonella spp., Escherichia coli, Staphylococcus aureus, bile-tolerant gram-negative bacteria, and Pseudomonas aeruginosa.

Under FDA’s 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements), manufacturers must establish component specifications that include microbiological limits, then verify those limits through testing. Acceptance criteria for finished oral dietary supplements under USP <1111> set TAMC at ≤ 1,000 CFU/g and TYMC at ≤ 100 CFU/g. For unprocessed raw materials of natural origin, some USP categories allow TAMC up to 10,000 CFU/g — but collagen, having undergone significant processing, is generally expected to arrive closer to finished-product benchmarks.

Salmonella must be absent in 10 grams of sample per USP <2022>. That “10 grams” specification matters more than most raw material buyers appreciate, and we’ll return to it.

Where Contamination Actually Originates in Collagen Supply Chains

Three post-processing stages generate the vast majority of microbial failures we see in collagen raw material submissions:

Spray drying and powder handling. Collagen peptide slurry exits the hydrolysis stage nearly sterile. But the spray dryer discharges powder into an ambient environment — typically a large, difficult-to-clean production space. If spray dryer cyclones, conveyors, and bagging equipment aren’t validated for cleaning between runs, biofilm-harbored organisms re-enter the product stream at the powder stage.

Bulk storage at origin. Collagen peptide powder is hygroscopic. A drum stored at 70°F with 65% relative humidity can reach water activity levels (aw > 0.65) where xerophilic molds can germinate within several weeks of packaging. Overseas warehousing conditions — particularly in coastal Chinese provinces where summer humidity regularly exceeds 80% — are rarely temperature- and humidity-controlled to the level U.S. brands would expect.

Transshipment and Midwest warehouse handling. Material imported from Asia or South America typically changes hands three to five times before reaching a Midwest supplement manufacturer. Each transfer point — freight forwarder, port warehouse, 3PL facility — is a potential contamination event. Drums that shift in transit can compromise bag liners. Temperature fluctuations during ocean freight create condensation inside sealed containers.

None of these failure points show up in a supplier COA generated at the factory gate.

What an Analytical Testing Laboratory Finds in Collagen Submissions

In reviewing microbiology data from collagen raw material submissions processed at our Chicago-area hub, TYMC failures are the most common finding. Yeast and mold counts in the 500–2,000 CFU/g range — well above the 100 CFU/g threshold — appear regularly in material that arrived with clean supplier COAs. The discrepancy nearly always traces to moisture exposure during transshipment rather than a manufacturing failure at origin.

Salmonella absence failures are less frequent but far more consequential. The requirement to demonstrate absence in 10 grams of sample means composite sampling is non-negotiable. A single 5-gram grab from the surface of a 500-kilogram drum is not a validated sampling plan under USP <2022>. Brands that rely on supplier COAs generated from single-point pulls — particularly from suppliers whose sampling SOPs haven’t been audited — are carrying unquantified regulatory exposure into their finished goods.

Available data from post-market surveillance studies and FDA warning letter patterns suggest discordance rates between supplier COAs and independent microbial test results run between 15% and 25% for animal-derived raw materials. That range is substantially higher than for chemically defined or synthetic ingredients, which lack the biological variability of materials derived from animal tissue. A Certificate of Analysis showing zero Salmonella is only as reliable as the sampling method behind it.

Building a Microbial Testing Protocol That Holds Up Under FDA Inspection

If you’re onboarding a new collagen supplier or scaling an existing SKU, the protocol that survives a 21 CFR Part 111 inspection looks like this:

1. Composite-sample every incoming lot. Pull subsamples from a minimum of 10 locations per drum, or across multiple drums from the same lot. Composite before submission. USP <2022> describes the approach for absence testing specifically.

2. Run USP <61> and <62> on every lot — not just at qualification. Supplier qualification data tells you about one production run. It tells you nothing about lot-to-lot variability in Salmonella presence or moisture-driven mold growth six months later.

3. Check water activity on receipt. A benchtop water activity meter reading above 0.65 on incoming collagen powder is a faster and cheaper early warning than waiting five days for a plate count. Quarantine and test any lot above that threshold before it moves downstream.

4. Establish a documented OOS investigation procedure. 21 CFR Part 111 requires one. Any lot that fails TAMC, TYMC, or a USP <62> specified organism needs documented investigation, supplier notification, and a disposition decision before the material is used in manufacturing.

5. Verify your analytical testing laboratory’s ISO 17025 scope. For microbiology work on dietary supplement components, the accreditation should specifically cover USP methods — not just a general CLIA certificate. The distinction matters when an FDA investigator reviews your lab records during inspection.

Marine collagen alone is projected to grow at 9.2% CAGR through 2030 as consumer demand for skin health and recovery supplements continues to expand. The brands building durable positions in this category are the ones treating each incoming lot of animal-derived raw material with the rigor they’d apply to a finished product — because under 21 CFR Part 111, the regulatory obligation to do exactly that is already in place.

The testing is cheap. The alternative isn’t.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025-Accredited USP Microbiology Testing for Supplement Components — Qalitex Laboratories performs accredited USP <61> and <62> testing on animal-derived and botanical raw materials received through our Illinois intake hub.